Jason A. Leverone

Companies

• OnKure Therapeutics, Inc.Chief financial officer Oct 8, 2024 to now¹
• Viridian Therapeutics, Inc.\DEChief financial officer Feb 13, 2017 to Jan 20, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• OTOnKure Therapeutics, Inc. OKUR18,500 shares³$39.9K at $2.15Sep 21, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 21, 2026Sold 302 shares at $2.97 of OnKure Therapeutics, Inc.³
• Jun 22, 2026Sold 303 shares at $4.40 of OnKure Therapeutics, Inc.⁴
• Mar 23, 2026Sold 301 shares at $4.16 of OnKure Therapeutics, Inc.⁵
• Dec 22, 2025Sold 302 shares at $2.97 of OnKure Therapeutics, Inc.⁶
• Sep 22, 2025Sold 303 shares at $2.62 of OnKure Therapeutics, Inc.⁷
• Jun 23, 2025Sold 303 shares at $2.38 of OnKure Therapeutics, Inc.⁸
• Apr 7, 2025Sold 1,844 shares at $2.67 of OnKure Therapeutics, Inc.⁹
• Apr 4, 2025Sold 1,278 shares at $3.33 of OnKure Therapeutics, Inc.⁹
• Oct 4, 2024Granted 16,331 shares of OnKure Therapeutics, Inc.¹⁰